Effect of lithium and rubidium on the ganglionic inhibitory action of norepinephrine

Abstract

Close intraarterial infusion of lithium chloride (2 and 4 mEq/kg) transiently suppressed evoked postganglionic potentials in the superior cervical ganglion of the cat; lower doses (0.5 and 1 mEq/kg) had no effect on transmission. Potentiation of the ganglionic inhibitory effect of norepinephrine (NE) occurred at plasma concentrations of lithium equivalent to those found to be therapeutic in man. Concurrent administration of lithium (1 mEq/kg) and doxepin (25 mcg/kg) produced greater facilitation of the ganglionic suppressant effect of NE than either lithium or doxepin alone. Rubidium chloride (0.1, 0.5 and 1 mEq/kg) produced temporary blockade of ganglionic transmission; lower doses (0.05 and 0.075 mEq/kg) did not exhibit a ganglioplegic effect. Reduction of the ganglionic inhibitory activity of NE was observed at each dose level of rubidium. Administration of doxepin (25 mcg/kg) immediately after rubidium (0.075 mEq/kg) significantly reduced the inhibitory effect of the cation on NE activity. These results suggest that, in the cat superior cervical ganglion, lithium may block NE uptake and rubidium may promote NE release.